Pipeline
| Drug candidate | Indication | Discovery | Pre-clinical | Phase I/II | Phase IIb/III |
|---|---|---|---|---|---|
| SL-28 |
Head and NeckOral cavityThyroid cancer
|
|
|||
| SL-28 |
ThoracicSmall-cell lung cancerNon-small cell lung cancerMesotheliomaEsophageal cancer
|
|
|||
| SL-28 |
GastrointestinalGastric cancerLiver cancerColorectal cancerPancreatic cancer
|
|
|||
| SL-28 |
GenitourinaryBladder cancerRenal cell carcinomaProstate cancer
|
|
|||
| SL-28 |
GynecologicOvarian cancerEndometrial cancer
|
|
|||
| SL-28 |
Breast and SkinBreast cancerMelanoma
|
|
|||